Bertrand Leo Chenard

Corporate Officer/Principal at Hydra Biosciences, Inc.

68 year

Health Technology

Consumer Services

Process Industries

Profile

Bertrand Leo Chenard is the founder of Cadent Therapeutics, Inc. (founded in 2010).
He is currently the Senior President-Chemistry & Pharmacology at Hydra Biosciences, Inc. Bertrand's former positions include being a Research Scientist-Central Research Department at EIDP, Inc., Senior Vice President-Chemistry & Process Research at Neurogen Corp., and a Project Coordinator & Research Advisor at Pfizer Inc. Bertrand's education includes an undergraduate degree from Central Connecticut State University and a doctorate from The Ohio State University.

Bertrand Leo Chenard active positions

Companies	Position	Start
Hydra Biosciences, Inc. Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA.	Corporate Officer/Principal	-

All active positions of Bertrand Leo Chenard

Former positions of Bertrand Leo Chenard

Companies	Position	End
Cadent Therapeutics, Inc. Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA.	Founder	-
PFIZER, INC.	Corporate Officer/Principal	-
E I DU PONT DE NEMOURS AND CO	Corporate Officer/Principal	-
Neurogen Corp. Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT.	Corporate Officer/Principal	-

See the detail of Bertrand Leo Chenard's experience

Training of Bertrand Leo Chenard

Central Connecticut State University	Undergraduate Degree
The Ohio State University	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Bertrand Leo Chenard's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
PFIZER, INC.	Health Technology

Private companies	4
Neurogen Corp. Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT.	Health Technology
EIDP, Inc. EIDP, Inc. Chemicals: AgriculturalProcess Industries EIDP, Inc. engages in the provision of science-based products and services. It operates through the Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms around the world. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded by Eleuthere Irenee du Pont in 1802 and is headquartered in Indianapolis, IN.	Process Industries
Hydra Biosciences, Inc. Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA.	Health Technology
Cadent Therapeutics, Inc. Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA.	Health Technology

See company connections